Skip to content

Evaluation of Locomotor Activity Before and After Total Hip Replacement in Patients With Hip Osteoarthritis.

Evaluation of Locomotor Activity Before and After Total Hip Replacement in Patients With Hip Osteoarthritis. Use of Ganglion and Neural Network Techniques to Identify Objective Criteria for the Success of Arthroplasty

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02042586
Enrollment
202
Registered
2014-01-23
Start date
2010-01-07
Completion date
Unknown
Last updated
2019-05-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip Osteoarthritis, Indication for Total Hip Replacement

Brief summary

The investigators believe that the application of non-linear methods of analysis using the ganglion and neural network technique will make it possible to analyse all of the complex data obtained in patients with hip osteoarthritis before and then after total hip replacement, and should allow us to identify a combination of objective variables to classify the surgery as successful or unsuccessful . To this end, the study will take place as follows: Step 1: Screening, and inclusion. Step 2: Evaluation of the hip osteoarthritis and analysis of locomotor activity Step 3: Total hip replacement Step 4: Clinical evaluation of locomotor activity carried out between 6 months and 1 year after the THR Step 5: Data analysis

Interventions

OTHERAnalysis of movement after total hip replacement
OTHERAnalysis of movement before total hip replacement

Sponsors

Centre Hospitalier Universitaire Dijon
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
25 Years to 85 Years
Healthy volunteers
Yes

Inclusion criteria

Control group: * Subjects who have provided written informed consent * Subjects covered by the national health insurance scheme * Men or women aged between 25 and 85 years * able to understand simple instructions and packaging instructions and able to give informed consent Patients group: * Patients who have provided written informed consent * Patients covered by the national health insurance scheme * Men or women aged between 25 and 85 years * able to understand simple instructions and packaging instructions and to give their informed consent * Suffering from hip osteoarthritis defined according to ACR criteria * Most recent radiography examination less than 6 months earlier * Radiological stage II, III or IV hip osteoarthritis according to the Kellgren and Lawrence classification * Presenting with an indication for total hip replacement, according to the surgeon's usual criteria

Exclusion criteria

Control group: * Hip osteoarthritis or other arthrosis in the lower limbs * Pregnant or breast-feeding women * Disorders that may interfere with gait analysis * Disorder that may be destabilized by gait analysis * Neurological disease and/or motor neuron disease Patients group: * Contra-indication for total hip replacement * Repeat surgery for total hip replacement * Impossibility to use a standard implant * Pregnant or breast-feeding women * Inflammatory flare of the hip osteoarthritis * Disorder that may interfere with gait analysis * Disorder that may be destabilized by gait analysis * Rapidly destructive hip osteoarthritis * Neurological disease and/or motor neuron disease * Hip dysplasia requiring THR to be completed using a graft

Design outcomes

Primary

MeasureTime frame
Degree of patient statisfactionBefore and between 6 months and 1 year after total hip replacement

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 19, 2026